Covered recipient · General Payments record
FRED SESTI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,427.55
- Reported across 167 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $631.84 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $171.76 | 2 |
| Novo Nordisk AS | $134.26 | 8 |
| Amgen Inc. | $58.29 | 3 |
| Lilly USA, LLC | $38.48 | 2 |
| EISAI INC. | $34.98 | 1 |
| PFIZER INC. | $33.32 | 2 |
| Daiichi Sankyo Inc. | $24.00 | 1 |
| Genmab U.S., Inc. | $22.27 | 1 |
| Kyowa Kirin, Inc. | $22.10 | 1 |
| GlaxoSmithKline, LLC. | $19.82 | 1 |
| Exact Sciences Corporation | $16.05 | 1 |
| Agios Pharmaceuticals, Inc. | $15.30 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.13 | 1 |
| ABBVIE INC. | $13.68 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.68 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108175008 | CMS |
| Agios Pharmaceuticals, Inc. | $15.30 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149643462 | CMS |
| Amgen Inc. | $19.19 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680112 | CMS |
| Amgen Inc. | $17.78 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680114 | CMS |
| Amgen Inc. | $21.32 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680116 | CMS |
| BeiGene USA, Inc. | $21.76 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120867184 | CMS |
| BeiGene USA, Inc. | $150.00 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120867182 | CMS |
| Daiichi Sankyo Inc. | $24.00 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089480749 | CMS |
| Eisai Inc. | $34.98 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110802060 | CMS |
| Exact Sciences Corporation | $16.05 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114886710 | CMS |
| Genmab U.S., Inc. | $22.27 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126835700 | CMS |
| GlaxoSmithKline, LLC. | $19.82 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116341724 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.40 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146758974 | CMS |
| Kyowa Kirin, Inc. | $22.10 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127049725 | CMS |
| Lilly USA, LLC | $18.30 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135650827 | CMS |
| Lilly USA, LLC | $20.18 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135638952 | CMS |
| Novo Nordisk Inc | $20.11 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100379329 | CMS |
| Novo Nordisk Inc | $17.74 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100360710 | CMS |
| Novo Nordisk Inc | $21.43 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550756 | CMS |
| Novo Nordisk Inc | $19.27 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100224280 | CMS |
| Novo Nordisk Inc | $2.75 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100295649 | CMS |
| Novo Nordisk Inc | $11.04 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100390886 | CMS |
| Novo Nordisk Inc | $22.46 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100492815 | CMS |
| Novo Nordisk Inc | $19.46 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100370617 | CMS |
| PFIZER INC. | $16.74 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131541997 | CMS |
| PFIZER INC. | $16.58 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131490913 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.13 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151204435 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.